Introduction {#S1}
============

Mammary gland development is phasic, with distinct developmental periods occurring in the embryo, at puberty and during pregnancy/lactation ([@B68]; [@B37]). The formation of the milk lines occurs at approximately embryonic day (E) 10 in mice and within 36 h resolves into five pairs of disk-shaped thickenings known as mammary placodes ([@B7]). At around E12.5, mammary placodes invaginate into the dermal mesenchyme forming the mammary buds, which later elongate and invade the fat pad precursor, creating a rudimentary epithelial tree ([@B7]; [@B47]; [@B33]). During embryonic development, multipotent mammary stem cells are replaced by unipotent luminal and basal stem/progenitor cells ([@B33]; [@B71]), with epithelial cell identities being resolved by E15.5 ([@B33]).

Initial postnatal growth of the mammary epithelium is proportional to body size and it is not until puberty that ductal elongation occurs, fueled by proliferation of adult mammary stem/progenitor cells within terminal end bud (TEB) structures ([@B11]; [@B37], [@B36]; [@B47]). Further epithelial expansion occurs during pregnancy to generate the functional (milk-producing) alveolar epithelium ([@B68]; [@B11]). With the cessation of infant suckling, alveolar mammary epithelial cells undergo massive programed cell death (a process known as post-lactational involution), returning the mammary gland to a near pre-pregnant state that is capable of supporting future pregnancies ([@B52]; [@B37]).

Mϕs are present in all adult tissues ([@B24]). These cells are first and foremost professional phagocytes, but also regulate tissue development, function and dysfunction ([@B22]; [@B42]; [@B72]). In the normal postnatal mammary gland, Mϕs regulate ductal morphogenesis during puberty ([@B16]; [@B66]; [@B27]), alveolar budding during ovarian cycling ([@B6]), alveologenesis in pregnancy ([@B49]) and tissue remodeling during post-lactational involution ([@B43], [@B44]; [@B21]), with many of these processes being impaired in mice deficient in tissue Mϕs. Moreover, Mϕs identified by fluorescence-activated cell sorting (FACS) of disaggregated tissue were detected within the embryonic mammary gland by E16.5 and fetal-derived Mϕs were apparently retained and expanded by self-renewal in adult mammary tissue ([@B29]).

With accumulating evidence demonstrating the dependence of the mammary epithelium on Mϕs at all developmental stages, it is tempting to speculate that tissue-resident Mϕs institute or influence a putative mammary stem cell niche, as has been shown for hematopoietic stem cells ([@B70]), intestinal stem cells ([@B56]) and hair follicle stem cells ([@B2]; [@B42]). Indeed, the activity of mammary "stem" or repopulating cells (defined as a subset of basal cells that are capable of recreating the bi-layered mammary epithelium upon limiting dilution transplantation) is reduced when cells are transplanted into the cleared fat pads of Mϕ-depleted recipient mice ([@B17]). More recently, mammary repopulating cells were shown to express a Notch ligand Delta like 1 (DLL1) and *Dll1*-conditional knockout mice showed reduced mammary repopulating activity and lower levels of F4/80^+^ Mϕs ([@B4]). Thus, it has been suggested that DLL1-expressing basal cells activate Notch-expressing Mϕs in a reciprocal stem cell-macrophage niche ([@B4]; [@B31]). Studies revealing developmental stage-dependent distribution of Mϕs in the mammary gland, including their sites of confluence, would provide further evidence for the existence of a stem cell-macrophage niche in this organ and may help to reveal the specific and stage-dependent localization of mammary stem/progenitor cells within the dynamic, bilayered epithelium under physiological conditions. Here, we utilize a fluorescent reporter model and optical tissue clearing techniques to reveal the presence, prevalence and position of Mϕs in the mammary gland at all phases of development.

Materials and Methods {#S2}
=====================

Reagents {#S2.SS1}
--------

Neutral buffered formalin (NBF), Quadrol^®^, triethanolamine and 4′,6-diamidino-2-phenylindole (DAPI) dilactate were purchased from Sigma Aldrich. Normal goat serum was purchased from ThermoFisher. Urea and sucrose were purchased from Chem-Supply. Triton-X-100 was purchased from VWR International. The following primary antibodies were used for immunostaining: chicken anti-GFP (Abcam, ab13970, batch \#s GR3190550-3 and -12), rat anti-F4/80 (Novus, NB600-404), rat anti-keratin 8 (DSHB, TROMA-I, batch \#s 7/7/16 and 30/3/17), rabbit anti-keratin 5 (BioLegend, 905504, batch \# B230397) and rabbit anti-SMA (Abcam, ab5694, batch \# GR3183259-26). The following secondary antibodies were used: goat anti-chicken Alexa Fluor-488 (ThermoFisher, A21236), goat anti-rat Cy3 (ThermoFisher, A10522) and goat anti-rabbit Alexa Fluor-647 (ThermoFisher, A21245).

Animal Models {#S2.SS2}
-------------

Animal experimentation was carried out in accordance with the *Australian Code for the Care and Use of Animals for Scientific Purposes* and the *Queensland Animal Care and Protection Act (2001)*, with local animal ethics committee approval. Animals were housed in individually ventilated cages with a 12 h light/dark cycle. Food and water were available *ad libitum*. *Csf1r-EGFP* (MacGreen) ([@B53]) mice were a kind gift from A/Prof Allison Pettit (Mater Research Institute-UQ). Mice were maintained as hemizygotes on a C57BL6/J background. C57BL6/J mice were obtained from the Animal Resources Center (Western Australia).

To obtain mammary tissue during gestation, female mice were mated and tissue harvested 14.5 days-post-coitus (mean no. embryos: 7; range: 6--9). GFP^+^ embryos (E14.5) were also harvested and analyzed after PCR-sexing. To obtain tissue during lactation, female mice were mated, allowed to litter naturally and lactating mammary tissue harvested on day 10 of lactation. For studies during involution, females were allowed to nurse for 10 days and mammary glands harvested 96 h post forced involution. Litter sizes were not standardized (mean litter size: 7; range: 5--10). Mammary glands from pre-pubertal female GFP^+^ mice (postnatal day 10), pubertal (6.5 weeks) and post-pubertal (12 weeks) were also harvested and analyzed. No estrus staging was performed in these studies. In all mice the 2nd, 3rd, 4th, and 5th mammary glands were excised and fixed as described above; 2nd/3rd and 5th mammary glands were preferentially selected for 3D imaging, owing to their smaller size.

CUBIC-Based Tissue Clearing and IHC {#S2.SS3}
-----------------------------------

Tissue clearing was performed as previously optimized and described ([@B11]; [@B35]). Briefly, mammary tissue was spread on foam biopsy pads and fixed for 6--9 h in NBF (10%). Embryos were fixed whole. For CUBIC-based clearing, tissue was immersed in Reagent 1A ([@B65]; [@B35]) at 37°C for 3 days before washing and blocking in goat serum (10%) in PBS with Triton-X-100 (0.5%) overnight at 4°C. Tissue was incubated in primary antibody in blocking buffer for 4 days and secondary antibody in blocking buffer for 2 days at 4°C. DAPI (5 μg/mL) treatment was performed for 2--3 h at room temperature \[omitted for second harmonic generation (SHG)\] and tissue was immersed in modified Reagent 2 ([@B35]) at 37°C for at least 24 h prior to imaging.

Immunohistochemistry (FFPE Slides) {#S2.SS4}
----------------------------------

IHC on FFPE slides was performed as previously described in detail ([@B63]). Wholemount immunostaining using anti-GFP antibody was performed prior to processing for paraffin embedding.

Microscopy {#S2.SS5}
----------

Immunostained tissue sections were imaged using an Olympus BX63 upright epifluorescence microscope using UPlanSAPO 10 × /0.4, 20 × /0.75, 40 × /0.95, 60 × /1.35, and 100 × /1.35 objective lenses. Immunostained optically cleared tissue was imaged using an Olympus FV3000 laser scanning confocal microscope with UPLSAPO 10 × /0.40, UPLSAPO 20 × /0.75, UPLSAPO 30 × /1.05, and UPLFLN 40 × /0.75 objective lenses. 3D de-noising was performed as previously described ([@B1]). For SHG, images were acquired using a Mai Tai DeepSee multiphoton laser on a Zeiss 710 laser scanning inverted microscope. Visualization and image processing was performed in ImageJ (v1.52e, National Institutes of Health) ([@B34]; [@B54]).

Results {#S3}
=======

Mϕs Are Present in the Embryonic Bud and Early Postnatal Gland With Sexually Dimorphic Distribution {#S3.SS1}
---------------------------------------------------------------------------------------------------

Mϕs have never been visualized in the embryonic mammary gland. A recent study by Jäppinen et al. revealed the presence of F4/80^+^ cells in digested mammary tissue by E16.5 by flow cytometry ([@B29]). However, in the absence of *in situ* imaging, it is currently unclear whether these embryonic Mϕs physically associate with the developing mammary epithelium, as has been observed in the postnatal gland.

To assess Mϕ distribution in 3-dimensions in intact mammary tissue, we used a *Csf1r-EGFP* mouse model ([@B53]), combined with methods for optical tissue clearing and deep tissue imaging ([Supplementary Figure S1](#SM1){ref-type="supplementary-material"}) ([@B11]; [@B35], [@B36]). In this model, green fluorescent protein (GFP) expression in tissues is restricted to monocytes and Mϕs in the developing embryo, starting with yolk sac-derived phagocytes, and in all adult tissues ([@B53]; [@B23]). Much lower expression in granulocytes and some B lymphocytes is detectable by FACS, but not in tissues. Multi-color fluorescence immunostaining of tissue sections from mouse spleen confirmed that the majority of GFP^+^ cells were also positive for the Mϕ cell surface marker, F4/80 ([Supplementary Figure S2](#SM1){ref-type="supplementary-material"}). Previous studies using digested mammary tissue from *Csf1r-EGFP* mice analyzed by flow cytometry have shown that \>90% of GFP^+^ cells in the mammary gland react with F4/80 ([@B6]; [@B20]).

In 3D image stacks of female *Csf1r-EGFP* embryos, Mϕs were detected in the mammary and dermal mesenchyme surrounding the mammary epithelial bud as early as E14.5 ([Figure 1A](#F1){ref-type="fig"} and [Supplementary Figure S3A](#SM1){ref-type="supplementary-material"}). As expected ([@B53]), Mϕs were also present in the embryonic liver at this stage ([Figure 1B](#F1){ref-type="fig"}), and it has been suggested that these fetal liver-derived Mϕs contribute extensively to the pool of tissue Mϕs present in the adult gland ([@B29]). Our data show that Mϕs were positioned adjacent to the embryonic mammary epithelium around the time of lineage segregation ([@B33]; [@B71]). Interestingly, although Mϕs were positioned around the embryonic bud, they were rarely observed to directly interact with the developing epithelium of female embryos ([Figure 1A](#F1){ref-type="fig"} and [Supplementary Figure S3A](#SM1){ref-type="supplementary-material"}). In contrast, Mϕs directly contacted and invaded the mammary bud of male mice at E14.5, the developmental period when the male bud is severed from the overlying epidermis in mice and begins to regress ([Figures 1C,D](#F1){ref-type="fig"} and [Supplementary Figure S3B](#SM1){ref-type="supplementary-material"}) ([@B13]; [@B19]; [@B7]). Mammary Mϕs were also observed in the early postnatal period in female mice ([Figures 1E,F](#F1){ref-type="fig"}). By this stage, however, Mϕs were positioned around and inside of this rudimentary structure, apparently interacting with the epithelium ([Figure 1E](#F1){ref-type="fig"}).

![Mϕs in the embryonic and early postnatal mouse mammary gland. Maximum intensity *z*-projection and single optical (*z*) slices of cleared tissue from **(A,B)** embryonic (E14.5) female mice and **(C)** embryonic (E14.5) male mice. **(D)** The distance of Mϕs (within a 100 μm radius) of the female and male embryonic buds. Mϕs contacting the bud or inside of the bud were assigned a value of 0; this was only observed in male embryos. **(E)** Mammary tissue from postnatal day (PND) 10 *Csf1r-EGFP* female mice. **(F)** Inguinal lymph node from PND10 mice showing subcapsular sinus Mϕs. Keratin (K) 8 immunostaining shows K8-positive luminal cells; K5 immunostaining reveals K5-expressing basal cells; smooth muscle actin (SMA) immunostaining reveals basal cells and SMA-positive vessels. White arrowhead in **(A)** points to a Mϕ that appears to be in contact with the embryonic bud in the maximum intensity projection, but is revealed to be positioned in the mammary mesenchyme above the bud in optical slices. Yellow arrowheads in **(C)** point to Mϕs that are in direct contact with the embryonic bud. Arrows in **(E)** point to Mϕs that are in contact with the PND10 mammary epithelium. Images are representative of 3 mice/embryos at each developmental stage.](fcell-07-00250-g001){#F1}

Mϕs Envelope and Infiltrate the Elongating Terminal End Bud During Ductal Morphogenesis {#S3.SS2}
---------------------------------------------------------------------------------------

Mϕs are essential for normal ductal morphogenesis during puberty ([@B16]; [@B66]; [@B27]). Pre-pubertal leukocyte depletion using sub-lethal γ-irradiation is associated with impaired ductal development and in Mϕ-deficient *Csf1^*op*^/Csf1^*op*^* mice, misshapen TEBs fail to properly invade the mammary fat pad at the rate observed in age-matched controls ([@B16]; [@B66]; [@B27]). Previous studies analyzing Mϕ density and distribution in mouse mammary tissue sections have shown recruitment of F4/80^+^ Mϕs to the pubertal epithelium and their convergence around the neck of TEBs ([@B16]; [@B55]), where adult mammary stem/progenitor cells are thought to reside ([@B59]; [@B37]).

3D imaging of mammary tissue from pubertal *Csf1r-EGFP* mice revealed that mammary TEBs were enveloped by Mϕs, with spatial clustering observed ([Figure 2A](#F2){ref-type="fig"} and [Supplementary Figure S4A](#SM1){ref-type="supplementary-material"}). Previous studies using the F4/80 marker indicated that Mϕs were mainly distributed at the neck of TEBs, whereas eosinophils (distinguished by their eosinic cytoplasm and bi-lobed nuclei) were concentrated at the TEB head ([@B16], [@B15]). By contrast, in this study GFP^+^ Mϕs in both locations shared stellate morphology ([Figure 2A](#F2){ref-type="fig"} and [Supplementary Figure S4A](#SM1){ref-type="supplementary-material"}) and neither showed any evidence of segmented nuclei ([Supplementary Figure S4A](#SM1){ref-type="supplementary-material"}). A small number of mammary Mϕs were observed inside the body of TEBs ([Figure 2A](#F2){ref-type="fig"}), where they may contribute to clearance of apoptotic cells from the TEB lumen ([@B26]; [@B16]; [@B47]). GFP^+^ Mϕs were found along the length of the ductal epithelium in the pubertal gland ([Figure 2B](#F2){ref-type="fig"} and [Supplementary Figure S4B](#SM1){ref-type="supplementary-material"}) and in some cases appeared to be positioned between the luminal and basal cell layers ([Figure 2B](#F2){ref-type="fig"}, arrow). Intraepithelial Mϕs, detected with F4/80, are a feature of ductal epithelia throughout the body ([@B25]). It is currently unclear how these interposed Mϕs affect luminal-basal cell connections \[e.g., desmosomes and gap junctions ([@B57])\] and their precise function within the epithelial bilayer. GFP^+^ cells were also dispersed throughout the mammary fat pad ([Figure 2](#F2){ref-type="fig"} and [Supplementary Figure S4](#SM1){ref-type="supplementary-material"}; [@B55]; [@B6]) and were densely packed in the inguinal lymph node ([Figure 2C](#F2){ref-type="fig"} and [Supplementary Figure S4B](#SM1){ref-type="supplementary-material"}) and nipple region ([Figure 2D](#F2){ref-type="fig"}).

![Mϕs in the mammary glands of pubertal virgin mice. Maximum intensity *z*-projection and single optical (*z*) slices of cleared mammary tissue from pubertal (6--7 week old) *Csf1r-EGFP* mice. K8 immunostaining reveals the luminal cell layer; SMA marks the basal cell layer and SMA-positive vessels. **(A)** terminal end buds (TEBs), **(B)** ductal regions, **(C)** inguinal lymph node, and **(D)** nipple region. Arrows in **(A)** show Mϕs that have invaded the TEB epithelium and lumen (arrowhead). Arrow in **(B)** shows a Mϕ positioned between the epithelial bilayer. T, ductal tips; Du, ducts; LN, lymph node. Images are representative of 3 mice. **(E)** Second harmonic generation (SHG) showing fibrillar collagens around a TEB structure. Image stacks in middle panel are depth-coded (R-Y-G-C-B). Dashed arrow shows direction of TEB growth. Arrowhead in **(E)** shows a Mϕ interacting with collagen.](fcell-07-00250-g002){#F2}

Mammary Mϕs have been shown to organize collagen into fibrillar bundles to steer TEB growth through the stromal fat pad ([@B27]). We therefore examined fibrillar collagens with SHG ([@B69]) in tissue from *Csf1r-EGFP* mice at depth using an immersion-based optical clearing approach, which preserves endogenous fluorescence and tissue architecture ([@B35]; [@B67]). Although surface collagen fibers in the mammary gland were dense and multi-directional \[[Figure 2E](#F2){ref-type="fig"} (red)\], deeper collagen fibers proximal to the growing TEB were aligned along its perimeter, extended in the direction of TEB growth and were associated with Mϕs ([Figure 2E](#F2){ref-type="fig"}). These data provide further evidence that mechanical forces from the stroma guide epithelial development in the normal mammary gland ([@B27]; [@B63]).

Mϕs Are Intimately Associated With the Mature Ductal Epithelium {#S3.SS3}
---------------------------------------------------------------

Mϕs are present in the post-pubertal mouse mammary gland at all phases of the estrus cycle, with the numbers being highest in diestrus ([@B6]). In tissue sections at all estrus stages, F4/80^+^ cells are detectable around alveolar side buds versus ducts, where they are thought to promote the development and regression of these transient structures ([@B6]). Using 3D imaging of mammary tissue from *Csf1r-EGFP* mice, we observed similar numbers of Mϕs closely associated with mammary ducts ([Figure 3A](#F3){ref-type="fig"} and [Supplementary Figure S5](#SM1){ref-type="supplementary-material"}) and side buds ([Figure 3B](#F3){ref-type="fig"} and [Supplementary Figure S5A](#SM1){ref-type="supplementary-material"}). As in the pubertal epithelium, Mϕs were also positioned between the luminal and basal cell layers in mature ducts and buds ([Figures 3A,B](#F3){ref-type="fig"} and [Supplementary Figure S5B](#SM1){ref-type="supplementary-material"}, arrowheads) with some evidence of periodicity in intraepithelial Mϕ placement ([Supplementary Figure S5B](#SM1){ref-type="supplementary-material"}). This is consistent with regular distributions of Mϕs in many locations throughout the body ([@B24]). SHG of mature ducts revealed some fibrillar collagens that were located around the ducts and vessels ([Supplementary Figure S5C](#SM1){ref-type="supplementary-material"}).

![Mϕs in the mammary glands of post-pubertal virgin mice. Maximum intensity *z*-projection and single optical (*z*) slices of cleared mammary tissue from post-pubertal (12 week-old) *Csf1r-EGFP* mice. K8 immunostaining shows luminal cells; SMA immunostaining reveals basal cells and SMA-positive vessels. **(A)** Mammary ducts and **(B)** side buds. Du, duct; B, side bud. Arrowheads show Mϕs that are positioned within the epithelial bilayer. K8 immunostaining reveals the luminal cell layer and SMA marks the basal cell layer. Images are representative of 3 mice.](fcell-07-00250-g003){#F3}

Mϕs Surround Alveolar Units in Gestation and Lactation {#S3.SS4}
------------------------------------------------------

Mϕ deficient *Csf1^*op*^/Csf1^*op*^* female mice have compromised fertility ([@B50]). Amongst those that do generate offspring, none are able to nurture a full litter, despite normal maternal behaviors ([@B49]). In-depth analyses of mammary tissue from pregnant and lactating *Csf1^*op*^/Csf1^*op*^* mice showed incomplete branching and precocious alveolar development ([@B49]) and F4/80^+^ cells have been detected around the developing and functional alveolar units during pregnancy and late gestation ([@B15]).

3D analysis of mammary tissue from pregnant *Csf1r-EGFP* mice (day 14.5 gestation, dG) confirmed Mϕ localization around the expanding alveolar structures ([Figure 4A](#F4){ref-type="fig"} and [Supplementary Figure S6](#SM1){ref-type="supplementary-material"}). By lactation, Mϕs were observed immediately adjacent to alveolar basal cells, where they frequently imitated basal cell morphology ([Figures 4B,C](#F4){ref-type="fig"}, white arrowheads). Mϕs were also present within lactational alveoli ([Figure 4C](#F4){ref-type="fig"}, arrow), consistent with their enrichment in breast milk ([@B14]).

![Mϕs in the mammary glands of pregnant and lactating mice. Maximum intensity *z*-projection and single optical (*z*) slices of cleared mammary tissue from **(A)** pregnant (14.5 days gestation, dG) and **(B,C)** lactating (day 10 lactation, d10) *Csf1r-EGFP* mice. K8 immunostaining reveals K8-positive luminal cells; smooth muscle actin (SMA) marks the basal/myoepithelial cells and SMA-positive vessels. Arrowheads in **(A)** show Mϕs that are interacting with the developing alveolar epithelium. In **(B,C)**, white arrowheads show Mϕs that are aligned along basal cells (versus white arrows showing Mϕs that are not imitating basal cell morphology). Yellow arrowheads in **(C)** show Mϕs that are positioned between the ductal epithelial bilayer. Images are representative of 3 mice at each developmental stage.](fcell-07-00250-g004){#F4}

The Irreversible Phase of Involution Is Associated With an Increase in Mϕ Number in and Around Regressing Alveolar Structures {#S3.SS5}
-----------------------------------------------------------------------------------------------------------------------------

The number of Mϕs surrounding the mammary epithelium increases drastically from days 3--4 of involution ([@B38]; [@B60]; [@B21]), and involution-associated Mϕs appear polarized toward tissue repair ([@B43]). The recruitment and polarization of Mϕs in the involuting mammary gland is regulated by epithelial *Stat3* expression ([@B21]). Moreover, pre-weaning depletion of CSF1R-expressing cells reduces mammary epithelial cell death during post-lactational involution, an effect that can be reversed by orthotopic transplantation of bone marrow-derived Mϕs ([@B44]).

To further examine Mϕ number, morphology and distribution in the regressing mammary gland in 3-dimensions, we analyzed optically clear tissue from *Csf1r-EGFP* mice during the irreversible phase of involution. Relative to other developmental stages, Mϕ density was high at 96 h involution and Mϕs were observed around and inside ducts and regressing alveoli ([Figures 5A,B](#F5){ref-type="fig"}). Large aggregates of GFP^+^ cells, reminiscent of homotypic fusion ([@B39]), were also observed inside degenerating alveolar structures ([Figure 5B](#F5){ref-type="fig"} arrowheads). Similar aggregates of GFP^+^ Mϕs have been observed in a model of epithelial regeneration in the kidney following transient ischemia ([@B30]).

![Mϕs in the mammary glands of mice during post-lactational involution. **(A--C)** Maximum intensity *z*-projection and single optical (*z*) slices of cleared mammary tissue from *Csf1r-EGFP* mice during involution (96 h post forced weaning). K8 immunostaining shows luminal cells; SMA immunostaining reveals basal cells and SMA-positive vessels. Arrowheads in **(B)** show a cluster of GFP^+^ Mϕs inside of collapsed alveolar units. **(C)** SHG showing fibrillar collagens surrounding regressing alveoli. Images are representative of 3 mice.](fcell-07-00250-g005){#F5}

Collagen density increases during mammary gland involution and partially degraded non-fibrillar collagens have been suggested to be chemotactic for Mϕs ([@B43]). Intra- and interlobular fibrillar collagens were observed with SHG in *Csf1r-EGFP* mice and GFP^+^ Mϕs were observed to be associated with collagen fibrils ([Figure 5C](#F5){ref-type="fig"}).

Discussion {#S4}
==========

Mϕs contribute to mammary gland development and remodeling at all developmental stages ([@B49]; [@B16]; [@B8]; [@B66]; [@B27]; [@B6]; [@B43], [@B44]; [@B21]). The exact mechanisms by which tissue Mϕs regulate these processes are still being elucidated ([@B55]) and may be linked to their phagocytic, trophic and/or matrix remodeling functions ([@B61]; [@B48]). A comprehensive characterization of the stage-specific physiological roles of Mϕs in the mammary gland depends upon knowledge of their precise anatomical location within this organ. In this study, we provide new insights into the allocation, morphology and distribution of Mϕs in the embryonic, pre-pubertal, pubertal, post-pubertal, pregnant, lactating and involuting mammary glands of fluorescent reporter-positive mice *in situ* in 3-dimensions ([Figure 6](#F6){ref-type="fig"}). Our study yields a number of important observations that could only be revealed by multi-dimensional imaging using a tamoxifen-independent, cell type-specific fluorescent reporter model ([@B24]; [@B23]). Firstly, in contrast to previous reports ([@B16], [@B15]), we demonstrate that Mϕs are not concentrated at the TEB neck, although some polarity in their distribution around TEBs was observed. These findings suggest that Mϕs may regulate mammary epithelial cells both within the head and neck of the TEB structure ([@B46]). Studies performing intravital imaging of TEB dynamics in *Csf1r-EGFP* mice are an aim for the future and may help to reveal possible correlations between Mϕ density and TEB behavior (e.g., turning and bifurcation events).

![Diagram summarizing Mϕ distribution in the mouse mammary gland during distinct phases of development and remodeling.](fcell-07-00250-g006){#F6}

Mammary Mϕs were also frequently embedded between luminal and basal cells of the ductal epithelium. This has previously been observed in mammalian ductal epithelia, including the bile duct, salivary gland, tracheobronchial gland and mammary gland using thin sections prepared from formalin-fixed paraffin-embedded or frozen tissue ([@B25]; [@B64]). Regularity in the spacing of these intraepithelial Mϕs was also noted, which may arise through mutual repulsion ([@B24]) and could potentially contribute to regular distribution of adjacent populations of heterogeneous luminal and basal cells ([@B28]; [@B11]). In sum, the work presented here suggests a close functional relationship between Mϕs and ductal epithelial cells, and possible communication between morphologically related Mϕ populations. Further studies are needed to determine whether these intraepithelial Mϕs share similar gene and protein expression patterns and whether this information can be used to probe their function, retention and passage within the epithelium. Tissue Mϕs have been shown to be influenced by properties of their specific niche within each tissue (e.g., anchoring scaffolds and local cues) ([@B3]; [@B40]). Single cell sequencing of isolated mammary Mϕs from *Csf1r-EGFP* mice at distinct developmental stages, as exemplified by recent studies of other tissues ([@B3]; [@B40]), might help to reveal the extent of functional diversity within Mϕ populations in this organ.

We reveal that Mϕs alter their morphology at distinct developmental stages, including the transition from gestation to lactation. The localization of Mϕs around growing alveolar units during gestation and the observation that Mϕ-deficient *Csf1^*op*^/Csf1^*op*^* mice exhibit precocious alveolar development, suggests that during this phase, alveolar-associated Mϕs may restrain alveologenesis. By analogy, Mϕs in the diaphragm appear to constrain the growth of lymphatic vessels and *Csf1r* mutation promoted branch formation of lymphatic sprouts ([@B45]). During lactation, Mϕs altered their anatomical position and were observed to closely imitate the morphology of adjacent, differentiated alveolar basal cells. Whether these cells specifically align themselves with oxytocin-responsive basal cells during lactation to modify basal cell function ([@B10]; [@B62]) or more simply to occupy the physical space that these force-exerting cells create within the alveolar epithelium ([@B9]; [@B63]), remains to be seen. Such a function might be analogous to the role of a distinct population of CSF1-dependent Mϕs in the regulation of peristalsis in the muscularis externa of the intestine ([@B41]). Interestingly, in this study muscularis Mϕs and intestinal motility could be reversibly modified by lumen factors ([@B41]). Whether mammary Mϕs, positioned alongside alveolar basal cells, are capable of sampling the alveolar lumen environment to constrain basal cell-mediated alveolar contractility (e.g., in mastitis) has not yet been determined. Another possibility is that basal cell contractility may instead alter the function of alveolar Mϕs. Such an effect has been observed in the lung, another organ that is subject to cyclical mechanical stimulation, although this phenomenon was restricted to newly recruited monocytes and not the population of resident alveolar Mϕs ([@B58]). Finally, we were able to visualize for the first time tissue-resident Mϕs in the mesenchyme surrounding the mammary epithelial bud in 14.5 day-old female embryos. Intriguingly, these embryonic Mϕs rarely contacted the epithelial cells of the developing mammary bud at this stage of embryogenesis. This is in striking contrast to epithelial-Mϕ interactions in the early postnatal period, where Mϕs surround and invade the rudimentary ductal epithelium. This also contrasts with the male embryo, where Mϕs were often observed to both contact and infiltrate the epithelial bud at the time when its connection to the overlying epidermis is severed and the structure begins to regress ([@B13]; [@B19]; [@B7]). At this stage, Mϕs may have an important role in clearing apoptotic epithelial and mesenchymal cells ([@B13]; [@B18]).

Mammary stem/progenitor cells are located within the mammary bud (in the embryo) and TEBs (in puberty). After ductal elongation is complete and TEBs regress, however, the location of long-lived mammary stem/progenitor cells and their putative niche remains unknown, although it has been suggested that these cells are deposited along the ductal epithelium by elongating TEBs ([@B11]; [@B37]). In the 14.5 day embryo, Mϕs were positioned uniformly around, but not in contact with, the mammary bud. These data suggest that if a mammary stem cell-macrophage niche exists in the embryo around the time of lineage segregation, it operates over the scale of tens of micrometers and is fairly homogeneous. Mϕs were also positioned around pubertal TEBs, however, in contrast to the embryo, these cells contacted and infiltrated TEBs, were more densely arranged around these structures and often showed spatial clustering. Future studies combining tamoxifen-independent *Dll1-mCherry* ([@B4]) and *Csf1r-EGFP* mouse models with optical tissue clearing and 3D imaging may help to reveal the precise location of mammary stem/progenitor cells within TEBs and the post-pubertal ductal epithelium. It should be noted, however, that whilst ductal elongation is delayed in *Csf1^*op*^/Csf1^*op*^* mice, these structures are still capable of invading the fat pad and by 12 weeks of age have reached the fat pad limits ([@B16]). These findings imply that mammary epithelial cells have mechanisms to overcome insufficiencies in niche signaling. One candidate is the alternative CSF1R ligand, IL34, which may also be expressed by mammary epithelial cells ([@B12]). Studies investigating the activation and roles of the CSF1R in mammary development have been thwarted by the severe postnatal phenotype of *Csf1r^--^/Csf1r^--^* mice ([@B5]), but may be more amenable to study in recently described *Csf1r^--^/Csf1r^--^* rats ([@B51]). Alternatively, these findings may reflect a long-term plasticity in mammary epithelial cells ([@B33]) and a shifting definition of "stemness" in some tissues away from a unidirectional, top-down model to a model where stemness is considered as a cell state that may be acquired or extinguished under specific microenvironmental conditions ([@B32]). A closer examination of mammary cell behaviors---including lineage segregation---under conditions of Mϕ depletion may provide important insights into epithelial plasticity in this vital mammalian organ.
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